Search in:

OncoImmunology Volume 7, 2018 - Issue 12

Submit an article Journal homepage

Open access

3,229

Views

CrossRef citations to date

Altmetric

Review

MDR1 in immunity: friend or foe?

Marion BossennecCentre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, LyonFrance;Immunology Virology Inflammation (IVI) department, Team “Therapeutic targeting of the tumor cells and their immune stroma”, Lyon, FranceCorrespondence[email protected]
View further author information

Anthony Di RoioCentre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, LyonFrance;Immunology Virology Inflammation (IVI) department, Team “Therapeutic targeting of the tumor cells and their immune stroma”, Lyon, FranceView further author information

Christophe CauxCentre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, LyonFrance;Immunology Virology Inflammation (IVI) department, Team “Therapeutic targeting of the tumor cells and their immune stroma”, Lyon, FranceView further author information

Christine Ménétrier-CauxCentre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, LyonFrance;Immunology Virology Inflammation (IVI) department, Team “Therapeutic targeting of the tumor cells and their immune stroma”, Lyon, FranceView further author information

Article: e1499388 | Received 14 Jun 2018, Accepted 08 Jul 2018, Published online: 06 Sep 2018

Cite this article
https://doi.org/10.1080/2162402X.2018.1499388
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (28)

Naike Casagrande, Cinzia Borghese, Michele Avanzo & Donatella Aldinucci. (2023) In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869. Cells 12:23, pages 2732.
Crossref

Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux & Christine Ménétrier-Caux. (2023) MDR1-expressing CD4 + T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response . Journal for ImmunoTherapy of Cancer 11:11, pages e007733.
Crossref

Hui-Yi Hsiao, Tzung-Hai Yen, Fang-Yu Wu, Chao-Min Cheng, Jia-Wei Liu, Yu-Ting Fan, Jung-Ju Huang & Chung-Yi Nien. (2023) Delivery and Transcriptome Assessment of an In Vitro Three-Dimensional Proximal Tubule Model Established by Human Kidney 2 Cells in Clinical Gelatin Sponges. International Journal of Molecular Sciences 24:21, pages 15547.
Crossref

Rafaella S. Coelho, Sandra M. Rocha & Cláudio J. Maia. (2023) Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions. BioChem 3:3, pages 118-141.
Crossref

Faezeh Tolue Ghasaban, Amirhosein Maharati, Amir Sadra Zangouei, Alireza Zangooie & Meysam Moghbeli. (2023) MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. Cancer Cell International 23:1.
Crossref

Yi Wang, Kaili Zhang, Yanjie Zhao, Yifan Li, Weijun Su & Shuai Li. (2023) Construction and Applications of Mammalian Cell-Based DNA-Encoded Peptide/Protein Libraries. ACS Synthetic Biology 12:7, pages 1874-1888.
Crossref

Yanling Zhao, Han Yan, Xue Liang, Zhenyu Zhang, Xuan Wang, Nianwei Shi, Weihong Bian, Qing Di & He Huang. (2022) Hydrogen Sulfide Attenuates Lipopolysaccharide-Induced Inflammation via the P-glycoprotein and NF-κB Pathway in Astrocytes. Neurochemical Research 48:5, pages 1424-1437.
Crossref

Kohei Ito, Marina Naoi, Kotaro Nishiyama, Takashi Kudo, Yasuhiro Tsuda, Caroline MacLean & Naoki Ishiguro. (2023) Impact of P-glycoprotein on intracellular drug concentration in peripheral blood mononuclear cells and K562 cells. Drug Metabolism and Pharmacokinetics 49, pages 100487.
Crossref

Stanislav Kotlyarov & Anna Kotlyarova. (2022) Clinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System. Membranes 12:11, pages 1083.
Crossref

Natalia Todosenko, Kristina Yurova, Olga Khaziakhmatova, Vladimir Malashchenko, Igor Khlusov & Larisa Litvinova. (2022) Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. Pharmaceutics 14:10, pages 2181.
Crossref

Carlos Pilotto Heming, Wanjiru Muriithi, Lucy Wanjiku Macharia, Paulo Niemeyer Filho, Vivaldo Moura-Neto & Veronica Aran. (2022) P-glycoprotein and cancer: what do we currently know?. Heliyon 8:10, pages e11171.
Crossref

Shuaijun Lu, Yang Li, Changling Zhu, Weihua Wang & Yuping Zhou. (2022) Managing Cancer Drug Resistance from the Perspective of Inflammation. Journal of Oncology 2022, pages 1-13.
Crossref

Kritika Engle & Gautam Kumar. (2022) Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. European Journal of Medicinal Chemistry 239, pages 114542.
Crossref

T. A. Bairova, N. V. Nemchinova, E. V. Belyaeva, A. Yu. Sambyalova, O. A. Ershova & L. V. Rychkova. (2022) The Prevalence of Polymorphic Variants of ABCB1 Gene among Indigenous Populations of Siberia. Russian Journal of Genetics 58:1, pages 57-64.
Crossref

Darren S Sigal, David J Hermel, Pei Hsu & Tillman Pearce. (2022) The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets. Future Oncology 18:1, pages 117-134.
Crossref

Giulia Scotto, Fulvio Borella, Margherita Turinetto, Valentina Tuninetti, Anna Valsecchi, Gaia Giannone, Stefano Cosma, Chiara Benedetto & Giorgio Valabrega. (2021) Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer. Cells 10:12, pages 3408.
Crossref

Melisa Intan Barliana, Arif Satria Wira Kusuma, Widya Norma Insani, Sofa Dewi Alfian, Ajeng Diantini, Mutakin Mutakin, Tina Rostinawati, Herlambang Herlambang, Irma Melyani Puspitasari, Auliya Abdurrohim Suwantika & Rizky Abdulah. (2021) Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in Indonesia. BMC Research Notes 14:1.
Crossref

Bruno Tello Rubio, Florence Bugault, Blandine Baudon, Bertrand Raynal, Sébastien Brûlé, Jean-David Morel, Sarah Saint-Auret, Nicolas Blanchard, Caroline Demangel & Laure Guenin-Macé. (2021) Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone. Frontiers in Pharmacology 12.
Crossref

Kazuhisa Sugiu, Hiroshi Tazawa, Joe Hasei, Yasuaki Yamakawa, Toshinori Omori, Tadashi Komatsubara, Yusuke Mochizuki, Hiroya Kondo, Shuhei Osaki, Tomohiro Fujiwara, Aki Yoshida, Toshiyuki Kunisada, Koji Ueda, Yasuo Urata, Shunsuke Kagawa, Toshifumi Ozaki & Toshiyoshi Fujiwara. (2021) Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer Chemotherapy and Pharmacology 88:3, pages 513-524.
Crossref

Stanislav Kotlyarov & Anna Kotlyarova. (2021) The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis. International Journal of Molecular Sciences 22:13, pages 6711.
Crossref

Dwaipayan Bhattacharya, Kalyani Sakhare, Kumar Pranav Narayan & Rajkumar Banerjee. (2021) The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer. Nanomedicine: Nanotechnology, Biology and Medicine 34, pages 102371.
Crossref

Maren de Vries, Adil S. Mohamed, Rachel A. Prescott, Ana M. Valero-Jimenez, Ludovic Desvignes, Rebecca O’Connor, Claire Steppan, Joseph C. Devlin, Ellie Ivanova, Alberto Herrera, Austin Schinlever, Paige Loose, Kelly Ruggles, Sergei B. Koralov, Annaliesa S. Anderson, Joseph Binder & Meike Dittmann. (2021) A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19 . Journal of Virology 95:10.
Crossref

Desh Deepak Singh, Ihn Han, Eun-Ha Choi & Dharmendra Kumar Yadav. (2021) CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer. Computational and Structural Biotechnology Journal 19, pages 2384-2397.
Crossref

Steven C. Koetzier, Jamie van Langelaar, Katelijn M. BlokThierry P.P. van den BoschAnnet F. Wierenga-WolfMarie-José MeliefKim PolTheodora A. SiepmanGeorges M.G.M. VerjansJoost Smolders, Erik LubbertsHelga E. de VriesMarvin M. van Luijn. (2020) Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS . Neurology Neuroimmunology & Neuroinflammation 7:6.
Crossref

Anna Seelig. (2020) P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers. Frontiers in Oncology 10.
Crossref

Sofia Waissbluth. (2020) Is Cyclosporine Ototoxic?. Frontiers in Neurology 11.
Crossref

Yachun Li, Dongjie Li, Ping Wang, Wei Zhu & Wanzhong Yin. (2020) Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells. Journal of International Medical Research 48:8, pages 030006052094470.
Crossref

Susann Badmann, Sabine Heublein, Doris Mayr, Anna Reischer, Yue Liao, Thomas Kolben, Susanne Beyer, Anna Hester, Christine Zeder-Goess, Alexander Burges, Sven Mahner, Udo Jeschke, Fabian Trillsch & Bastian Czogalla. (2020) M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis. Cells 9:5, pages 1224.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

MDR1 in immunity: friend or foe?

Articles from other publishers (28)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

MDR1 in immunity: friend or foe?

Citations (28)

Articles from other publishers (28)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date